Agalakova, N.I.; Mikhailova, E.V.; Ershov, I.A.; Nadei, O.V.; Pyankov, A.A.; Galagoudza, M.M.; Adair, C.D.; Romanova, I.V.; Bagrov, A.Y.
Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease. Int. J. Mol. Sci. 2024, 25, 8896.
https://doi.org/10.3390/ijms25168896
AMA Style
Agalakova NI, Mikhailova EV, Ershov IA, Nadei OV, Pyankov AA, Galagoudza MM, Adair CD, Romanova IV, Bagrov AY.
Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease. International Journal of Molecular Sciences. 2024; 25(16):8896.
https://doi.org/10.3390/ijms25168896
Chicago/Turabian Style
Agalakova, Natalia I., Elena V. Mikhailova, Ivan A. Ershov, Olga V. Nadei, Arseny A. Pyankov, Michael M. Galagoudza, C. David Adair, Irina V. Romanova, and Alexei Y. Bagrov.
2024. "Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease" International Journal of Molecular Sciences 25, no. 16: 8896.
https://doi.org/10.3390/ijms25168896
APA Style
Agalakova, N. I., Mikhailova, E. V., Ershov, I. A., Nadei, O. V., Pyankov, A. A., Galagoudza, M. M., Adair, C. D., Romanova, I. V., & Bagrov, A. Y.
(2024). Antibody to Endogenous Cardiotonic Steroid Reverses Vascular Fibrosis and Restores Vasorelaxation in Chronic Kidney Disease. International Journal of Molecular Sciences, 25(16), 8896.
https://doi.org/10.3390/ijms25168896